WASHINGTON -(Dow Jones)- The Federal Trade Commission on Tuesday approved dialysis clinic operator DaVita Inc.'s (DVA) $3.1 billion purchase of rival Gambro Healthcare Inc.,

http://c.moreover.com/click/here.pl?r402114017